In the current study, we first found that K15 promoter-driven enforced expression of NKIRAS2 in follicle bulges exhibits potent tumor suppressive activity against the development of skin papilloma induced by treatment with DMBA and TPA (Fig. 4). The gene discussed is NKIRAS2; the disease is neoplasm.